Allied Market Research forecasts a 5.8% CAGR, citing increased prevalence of chronic diseases and menopausal issues as key drivers.
Isoflavones are emerging as a natural alternative for managing health issues, said Allied Market Research.— Allied Market Research
WILMINGTON,NEW CASTLE, DELAWARE, UNITED STATES, July 18, 2024 /
EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “
Isoflavones Market by source, application, and form: global opportunity analysis and industry forecast, 2021–2030,” the global isoflavones market size is expected to reach $1,707.5 million by 2030 at a CAGR of 5.8% from 2021 to 2030.
📍𝐀𝐬𝐤 𝐟𝐨𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 :
https://www.alliedmarketresearch.com/request-sample/A13139
Isoflavones are a type of organic compound that is related to flavonoids and act as a phytoestrogen. Soybeans, red clover, chickpeas, green peas, and alfalfa are its common sources. They are used in the production of cosmetics and various skin care products such as moisturizers and face creams. Isoflavones are also widely used in the pharmaceutical industry to treat a variety of diseases.
Rise in prevalence of chronic diseases and cancer, technological advancements in the manufacture of isoflavones, and the rapidly growing geriatric population are the primary drivers of the market. Stringent regulatory requirements and unfavorable drug price control policies in various countries, on the other hand, are significant isoflavones market trends that are expected to limit the market's growth to some extent.
Isoflavones are a class of phytoestrogens, plant-derived compounds with estrogenic activity, predominantly found in soybeans and soy products. They are structurally similar to human estrogen and can exert weak estrogenic effects by binding to estrogen receptors in the body. This unique characteristic has drawn significant interest from the scientific community due to their potential health benefits. Isoflavones are primarily composed of three types: genistein, daidzein, and glycitein. Each of these has distinct biological activities and potential health implications, making isoflavones a compelling area of research in nutrition and medicine.
One of the most studied benefits of isoflavones is their role in reducing the risk of certain cancers, particularly breast and prostate cancers. Epidemiological studies have suggested that populations consuming a diet rich in soy isoflavones have lower incidences of these cancers. The proposed mechanisms include the inhibition of cancer cell proliferation, induction of apoptosis (programmed cell death), and inhibition of angiogenesis (the formation of new blood vessels that feed tumors). Isoflavones may also modulate hormone metabolism and interfere with the binding of estrogen to its receptors, thus potentially reducing the risk of hormone-dependent cancers.
Isoflavones have also been shown to have cardiovascular benefits. They may help to lower cholesterol levels, improve arterial health, and reduce the risk of atherosclerosis (the buildup of fats, cholesterol, and other substances in and on the artery walls). Clinical studies have demonstrated that consuming isoflavone-rich foods can lead to modest reductions in total cholesterol and low-density lipoprotein (LDL) cholesterol, which is often referred to as "bad" cholesterol. Additionally, isoflavones possess antioxidant properties, which can help prevent the oxidation of LDL cholesterol, a key step in the development of atherosclerosis.
Growing prevalence of menopausal issue is boosting the market growth. Women going through menopause face a variety of issues, including hot flashes, insomnia, and sexual dysfunction. Many women prefer estrogen-containing supplements, which may increase the risk of blood clots, stroke, or breast or uterine cancer. As a result, depending on their health and family health history, estrogen may not be an option for many women. Women are increasingly turning to supplements containing naturally therapeutic ingredients to help them manage menopausal symptoms safely. Manufacturers of supplements have turned to natural alternatives in response to women's changing preferences. They have begun to use soy isoflavones instead of estrogen as it resembles estrogen characteristics and provides estrogen effects that aid in the reduction of menopausal symptoms such as hot flashes and fatigue. The isoflavones market demand from the nutraceutical industry is expected to grow in the coming years, owing to the growing issues related to menopause and women's preference for supplements with natural alternatives.
📍𝐁𝐮𝐲 𝐍𝐨𝐰:
https://www.alliedmarketresearch.com/checkout-final/15dd2d990b142a1d6f8cb9a52829f7e0
The isoflavones market is segmented on the basis of source, application, form, and region. On the basis of source, it is categorized into soy, red clover, and others. As per application, it is divided into pharmaceuticals, nutraceuticals, cosmetics, and food & beverages. According to form, it is fragmented into powder and liquid. Region-wise, the isoflavones market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By source, the soy segment garnered the highest market share in 2020 due to rising consumer awareness of the benefits of consuming soy isoflavones in regular diet such as the prevention and treatment of heart disease, asthma, diabetes, and multiple cancers. On the basis of application, the pharmaceuticals segment is anticipated to dominate with the highest market share during the forecast period. This is attributed to the growing application of isoflavones due to their therapeutic and functional properties. By form, the powder segment led the market in 2020. This is attributed to factors such as ease of handling and use of isoflavones in a wide range of pharmaceutical and nutraceutical applications.
In the coming years, Asia-Pacific and North American countries are expected to drive the market growth. The primary drivers of the market growth in these regions are expected to be rising disposable income and increasing demand for dietary supplements. The major contributors to the isoflavones market are applications of isoflavones in food & beverages and pharmaceuticals.
The prominent isoflavones industry players include Cargill, Archer-Daniels-Midland (ADM) Company, Badische Anilin und Soda Fabrik (BASF), DSM, International Flavors and Fragrances, Shanghai Freemen, Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Herbo Nutra, and NutraScience Labs.
The most important growth strategy used by the isoflavones market players is product launch, which is followed by collaboration, agreement, expansion, and acquisition. To diversify their product offerings, several isoflavones industry players have developed innovative products. Product launches are used by a variety of businesses to broaden their market reach and serve international customers.
📍𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐏𝐫𝐨𝐜𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐕𝐢𝐬𝐢𝐭 𝐇𝐞𝐫𝐞 :
https://www.alliedmarketresearch.com/isoflavones-market/purchase-options
Bone health is another area where isoflavones have shown promise. As phytoestrogens, they can mimic the effects of estrogen in the body, which is particularly beneficial for postmenopausal women who experience a decline in estrogen levels. Estrogen is crucial for maintaining bone density, and its deficiency can lead to osteoporosis, a condition characterized by weak and brittle bones. Studies have indicated that isoflavone supplementation can help improve bone mineral density and reduce the risk of fractures in postmenopausal women, making them a potential natural alternative to hormone replacement therapy.
In addition to their physical health benefits, isoflavones may also have positive effects on mental health. Preliminary research suggests that they might improve cognitive function and reduce the risk of neurodegenerative diseases such as Alzheimer's. The estrogenic activity of isoflavones is believed to play a role in protecting brain cells and promoting neural health. Some studies have shown that regular consumption of isoflavone-rich foods is associated with better memory and cognitive performance in older adults, although more research is needed to confirm these findings and understand the underlying mechanisms.
Despite their numerous potential benefits, the consumption of isoflavones and soy products is not without controversy. Concerns have been raised about their estrogen-like effects and the possibility of disrupting endocrine function. However, the majority of research suggests that moderate consumption of soy and isoflavones is safe for most people. It is important to note that individual responses to isoflavones can vary, and factors such as age, sex, and overall diet can influence their effects. As with any dietary component, balance and moderation are key.
In conclusion, isoflavones are a fascinating group of compounds with a wide range of potential health benefits, from cancer prevention and cardiovascular health to bone and mental health. While more research is needed to fully understand their effects and optimal intake levels, incorporating isoflavone-rich foods like soybeans into a balanced diet can be a beneficial strategy for promoting overall health and well-being. As with any dietary intervention, it is advisable to consult with healthcare professionals to tailor recommendations to individual health needs and conditions.
📍𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲
- - The isoflavones market was valued at $975.0 million in 2020, and is estimated to reach $1,707.5 million by 2030, growing at a CAGR of 5.8% during the forecast period.
- - By source, the others segment is estimated to witness the fastest growth, registering a CAGR of 6.3% during the forecast period.
- - In 2020, depending on application, the pharmaceutical segment was valued at $435.6 million, accounting for 44.6% of the global isoflavones market share.
- - In 2020, the North America was the most prominent market, and is projected to reach $539.6 million by 2030, growing at a CAGR of 5.2% during the forecast period.
📝 𝐀𝐛𝐨𝐮𝐭 𝐔𝐬
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view of providing business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domain.
We have professional corporate relations with various companies and this helps us dig out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high-quality of data and help clients in every way possible to achieve success. Each and every piece of data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
📞𝐂𝐨𝐧𝐭𝐚𝐜𝐭
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (toll-free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:
https://www.alliedmarketresearch.com/reports-store/food-and-beverages
Follow Us on Blog:
https://www.dailyreportsworld.com/David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter